Gabelli Funds’s Zosano Pharma Corporation ZSAN Stock Holding History

Gabelli Funds’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-608	Closed	-$5K	–	1473
2022 Q1	$5K	Hold	608	–	–	﹤0.01%	1425
2021 Q4	$10K	Hold	608	–	–	﹤0.01%	1426
2021 Q3	$15K	Hold	608	–	–	﹤0.01%	1381
2021 Q2	$20K	Hold	608	–	–	﹤0.01%	1343
2021 Q1	$26K	Hold	608	–	–	﹤0.01%	1310
2020 Q4	$11K	Hold	608	–	–	﹤0.01%	1210
2020 Q3	$35K	Hold	608	–	–	﹤0.01%	1109
2020 Q2	$18K	Hold	608	–	–	﹤0.01%	1055
2020 Q1	$12K	Hold	608	–	–	﹤0.01%	1069
2019 Q4	$32K	Hold	608	–	–	﹤0.01%	1084
2019 Q3	$33K	Hold	608	–	–	﹤0.01%	1109
2019 Q2	$70K	Hold	608	–	–	﹤0.01%	1123
2019 Q1	$102K	Hold	608	–	–	﹤0.01%	1106
2018 Q4	$45K	Hold	608	–	–	﹤0.01%	1127
2018 Q3	$87K	Buy	608 +142	+30%	+$20.8K	﹤0.01%	1133
2018 Q2	$66K	Buy	+466	New	+$70.1K	﹤0.01%	1135

Other funds holding ZSAN

CDIA

Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Gabelli Funds's ZSAN Position: Q2 2022 in Review

Gabelli Funds sold out of Zosano Pharma Corporation (ZSAN) in Q2 2022, closing a stake of 608 shares — an estimated $5K sold.

Gabelli Funds first reported a position in ZSAN in Q2 2018 and held it in 16 quarters. The position peaked at $102K in Q1 2019. 3 funds tracked by Wall St. Rank hold ZSAN as of Q2 2022.

Gabelli Funds reported no remaining Zosano Pharma Corporation position as of Q2 2022 after selling out during the quarter.
Gabelli Funds sold 608 Zosano Pharma Corporation shares in Q2 2022, an estimated $5K.
Gabelli Funds first reported a position in Zosano Pharma Corporation in Q2 2018 and held it in 16 quarters.
Gabelli Funds's Zosano Pharma Corporation position peaked at $102K in Q1 2019.
3 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2022.

Based on Gabelli Funds's 13F filing for Q2 2022, filed 12 Aug 2022.